Analytical Data
-
Gene name
CD302
- Application
-
Alternative Names
BIMLEC; C type lectin BIMLEC; C type lectin domain family 13 member A; C-type lectin BIMLEC; C-type lectin domain family 13 member A; CD302; CD302 antigen; CD302_HUMAN; CLEC13A; DCL1; KIAA0022; Type I transmembrane C type lectin receptor DCL-1; Type I transmembrane C-type lectin receptor DCL-1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IX05
-
Expression Region
1-232aa
-
AA Sequence
MLRAALPALLLPLLGLAAAAVADCPSSTWIQFQDSCYIFLQEAIKVESIEDVRNQCTDHGADMISIHNEEENAFILDTLKKQWKGPDDILLGMFYDTDDASFKWFDNSNMTFDKWTDQDDDEDLVDTCAFLHIKTGEWKKGNCEVSSVEGTLCKTAIPYKRKYLSDNHILISALVIASTVILTVLGAIIWFLYKKHSDSRFTTVFSTAPQSPYNEDCVLVVGEENEYPVQFD
-
Molecular Weight
26.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CD302, also known as the C-type lectin domain family 13 member A, is a type of receptor that plays a significant role in immune response and cell adhesion. It is primarily expressed on dendritic cells and macrophages, where it is involved in pathogen recognition and modulation of immune responses. The study of recombinant CD302 protein has garnered interest due to its potential applications in immunotherapy and vaccine development. Understanding the structural and functional properties of CD302 can provide insights into its role in antigen presentation and the activation of T cells, which are crucial for an effective immune response. Additionally, CD302 has been implicated in various diseases, including cancer and autoimmune disorders, making it a valuable target for therapeutic interventions. Researchers focus on producing recombinant CD302 to investigate its binding interactions and signaling pathways, which may lead to novel strategies for enhancing immune responses against tumors or infectious agents. The development of recombinant CD302-based assays and therapies could ultimately contribute to advancements in personalized medicine and improved treatment outcomes for patients with immunological conditions.
